Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart
Publishing timestamp: 2024-03-27 16:40:27
Summary
Altimmune's experimental drug in midstage trial helped patients shed weight while minimizing loss of muscle mass, potentially setting it apart in the weight loss drug market. Results show promise in addressing concerns around muscle mass loss associated with weight loss treatments. Other biotech companies are also working on weight loss drugs with a focus on preserving muscle mass.
Sentiment: POSITIVE
Tickers: NVO, LLY, NOVO.B-DK, ALT,
Keywords: business news, biotech and pharmaceuticals, eli lilly and co, novo nordisk a/s, biotechnology, science, pharmaceuticals, altimmune inc, health care industry, weight management, business,
Source: https://www.cnbc.com/2024/03/27/altimmune-weight-loss-drug-minimized-muscle-mass-loss-in-trial.html